Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Objective</h3><p>Small cell carcinoma of the esophagus (SCCE) is a rare type of esophageal cancer, and the parameters for prediction of SCCE outcome are unclear. This study aimed to construct a nomogram for predicting outcome of SCCE.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Research Methods & Procedures</h3><p>Patients who underwent treatments at Sun Yat-Sen University Cancer Center were recruited and divided randomly into training and validation cohorts (61 and 32 patients, respectively). Cox regression analysis was utilized to identify independent prognostic factors for establishing a nomogram for predicting overall survival (OS) and disease-free survival (DFS).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>Pretreatment nutritional candidate hemoglobin and inflammation related neutrophil-to-lymphocyte ratio and platelet count were entered into the nomogram. In the training cohort, the C-index of the nomogram for OS was 0.728, higher than that obtained by TNM staging (0.614; <em>p</em> = 0.014). A significant difference was observed in the nomogram for DFS (0.668 vs. TNM stage: 0.616; p = 0.014) Similar results were found in the validation group. The decision curve analysis, net reclassification improvement and integrated discrimination improvement showed moderate improvement of the nomogram in predicting survival. Based on the cut-point calculated according to the constructed-nomogram, the high-risk group had the poorer OS and DFS than the low-risk group in both cohorts (all <em>p</em> < 0.05). Moreover, the DFS of patients receiving surgery in the high-risk group was better than that of patients receiving single radiotherapy or chemotherapy (<em>p</em> = 0.0111).</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>A nomogram based on the nutrition and inflammation-related indicators was developed for prediction of SCCE patient survival.</p>

Nomogram based on nutritional and inflammatory indicators for survival prediction of small cell carcinoma of the esophagus